Thromboembolism and Bleeding in COVID-19
Coronavirus disease 2019 (COVID-19) is characterized by a coagulation dysfunction which has different underlying mechanisms and factors. Patients with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection have an increased risk for thromboembolic and bleeding complications. Incidenc...
Main Author: | Koray Durak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | J |
Subjects: | |
Online Access: | https://www.mdpi.com/2571-8800/4/3/36 |
Similar Items
-
Risk factors for Venous thromboembolism and duration of anticoagulation therapy
by: Antonijević Nebojša M., et al.
Published: (2013-01-01) -
Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis
by: Gerald Chi, et al.
Published: (2020-08-01) -
Venous Thromboembolism in COVID-19: Are Women Different?
by: Shibba Takkar Chhabra, et al.
Published: (2020-09-01) -
Venous Thromboembolism Prophylaxis and The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) Score in Medical Illness Patients
by: Dania Artriana Riswandi, et al.
Published: (2020-04-01) -
Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection
by: Christian Zanza, et al.
Published: (2021-01-01)